{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:01:14Z","timestamp":1790730074579,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001067","name":"Juvenile Diabetes Research Foundation Australia","doi-asserted-by":"publisher","award":["466658"],"award-info":[{"award-number":["466658"]}],"id":[{"id":"10.13039\/501100001067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["MCRF16009"],"award-info":[{"award-number":["MCRF16009"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["14-1197"],"award-info":[{"award-number":["14-1197"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1020363"],"award-info":[{"award-number":["1020363"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1046010"],"award-info":[{"award-number":["1046010"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1080498"],"award-info":[{"award-number":["1080498"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1008614"],"award-info":[{"award-number":["1008614"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1016701"],"award-info":[{"award-number":["1016701"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["361646"],"award-info":[{"award-number":["361646"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["7001-13"],"award-info":[{"award-number":["7001-13"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["7413"],"award-info":[{"award-number":["7413"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011713","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003747","name":"Department of Health, State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015896","name":"Cancer Therapeutics Cooperative Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","award":["1047672"],"award-info":[{"award-number":["1047672"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000951","name":"Cancer Council Victoria","doi-asserted-by":"publisher","award":["1161400"],"award-info":[{"award-number":["1161400"]}],"id":[{"id":"10.13039\/501100000951","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1053\/j.gastro.2020.06.039","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T09:10:22Z","timestamp":1592644222000},"page":"1444-1458.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Loss of NFKB1 Results in Expression of Tumor Necrosis Factor and Activation of Signal Transducer and Activator of Transcription 1 to Promote Gastric Tumorigenesis in Mice"],"prefix":"10.1053","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6260-0595","authenticated-orcid":false,"given":"Jun T.","family":"Low","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Dumoutier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Preaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.W.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy L.","family":"Putoczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine A.","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2020.06.039_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.gastro.2020.06.039_bib2","first-page":"26","article-title":"Epidemiology of gastric cancer: global trends, risk factors and prevention","volume":"14","author":"Rawla","year":"2019","journal-title":"Prz Gastroenterol"},{"key":"10.1053\/j.gastro.2020.06.039_bib3","first-page":"6735","article-title":"Human gastric carcinogenesis: a multistep and multifactorial process\u2014First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention","volume":"52","author":"Correa","year":"1992","journal-title":"Cancer Res"},{"key":"10.1053\/j.gastro.2020.06.039_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.critrevonc.2018.10.007","article-title":"Immunotherapy in advanced gastric cancer, is it the future?","volume":"133","author":"Coutzac","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1053\/j.gastro.2020.06.039_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","article-title":"Dangerous liaisons: STAT3 and NF-\u03baB collaboration and crosstalk in cancer","volume":"21","author":"Grivennikov","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1053\/j.gastro.2020.06.039_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 years of NF-\u03baB: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"key":"10.1053\/j.gastro.2020.06.039_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.immuni.2018.03.003","article-title":"Loss of NF-\u03baB1 causes gastric cancer with aberrant inflammation and expression of immune checkpoint regulators in a STAT-1-dependent manner","volume":"48","author":"O\u2019Reilly","year":"2018","journal-title":"Immunity"},{"key":"10.1053\/j.gastro.2020.06.039_bib8","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1136\/gutjnl-2018-316691","article-title":"Diverse tumour susceptibility in Collaborative Cross mice: identification of a new mouse model for human gastric tumourigenesis","volume":"68","author":"Wang","year":"2019","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2020.06.039_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cyto.2015.11.011","article-title":"The good and the bad faces of STAT1 in solid tumours","volume":"89","author":"Meissl","year":"2017","journal-title":"Cytokine"},{"key":"10.1053\/j.gastro.2020.06.039_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcancer.2019.10.002","article-title":"The potential and controversy of targeting STAT family members in cancer","volume":"60","author":"Verhoeven","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.gastro.2020.06.039_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fonc.2018.00287","article-title":"\u201cDo we know jack\u201d about JAK? A closer look at JAK\/STAT signaling pathway","volume":"8","author":"Bousoik","year":"2018","journal-title":"Front Oncol"},{"key":"10.1053\/j.gastro.2020.06.039_bib12","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/annonc\/mdv026","article-title":"Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies","volume":"26","author":"Wong","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1053\/j.gastro.2020.06.039_bib13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/onc.2015.150","article-title":"Targeting JAK kinase in solid tumors: emerging opportunities and challenges","volume":"35","author":"Buchert","year":"2016","journal-title":"Oncogene"},{"key":"10.1053\/j.gastro.2020.06.039_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O\u2019Shea","year":"2015","journal-title":"Annu Rev Med"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2020.06.039_bib15","doi-asserted-by":"crossref","first-page":"i43","DOI":"10.1093\/rheumatology\/key276","article-title":"JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis","volume":"58","author":"Fragoulis","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.gastro.2020.06.039_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.12688\/f1000research.13167.1","article-title":"JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders","volume":"7","author":"Vainchenker","year":"2018","journal-title":"F1000Res"},{"key":"10.1053\/j.gastro.2020.06.039_bib17","doi-asserted-by":"crossref","first-page":"108251","DOI":"10.1016\/j.clim.2019.108251","article-title":"Targeting cytokines to treat autoimmunity","volume":"206","author":"Kyttaris","year":"2019","journal-title":"Clin Immunol"},{"issue":"11","key":"10.1053\/j.gastro.2020.06.039_bib18","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.3390\/ijms19113402","article-title":"Targeting cytokines as evolving treatment strategies in chronic inflammatory airway diseases","volume":"19","author":"Garth","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.gastro.2020.06.039_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2018.04.001","article-title":"Cytokine targeting in rheumatoid arthritis","volume":"206","author":"Bui","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1053\/j.gastro.2020.06.039_bib20","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3748\/wjg.v16.i10.1188","article-title":"Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer","volume":"16","author":"Sugimoto","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.06.039_bib21","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s13277-014-2810-3","article-title":"Association of interleukin 22 polymorphisms with gastric cancer risk","volume":"36","author":"Qin","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1053\/j.gastro.2020.06.039_bib22","first-page":"23","article-title":"IL-6 and IL-11 as markers for tumor aggressiveness and prognosis in gastric adenocarcinoma patients without mutations in gp130 subunits","volume":"21","author":"Necula","year":"2012","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"key":"10.1053\/j.gastro.2020.06.039_bib23","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/bjc.2014.336","article-title":"IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling","volume":"111","author":"Fukui","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1053\/j.gastro.2020.06.039_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1471-2407-14-357","article-title":"Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy","volume":"14","author":"Ruzzo","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1053\/j.gastro.2020.06.039_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1440-1746.2006.04442.x","article-title":"Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer","volume":"22","author":"Sugimoto","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.06.039_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcmgh.2017.03.005","article-title":"Regulation of gastric carcinogenesis by inflammatory cytokines","volume":"4","author":"Bockerstett","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.06.039_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fphys.2018.00469","article-title":"Relationship between tumor necrosis factor-\u03b1 rs361525 polymorphism and gastric cancer risk: a meta-analysis","volume":"9","author":"Xu","year":"2018","journal-title":"Front Physiol"},{"key":"10.1053\/j.gastro.2020.06.039_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3892\/br.2017.934","article-title":"The relationship between tumor necrosis factor-\u03b1 polymorphisms and gastric cancer risk: an updated meta-analysis","volume":"7","author":"Zheng","year":"2017","journal-title":"Biomed Rep"},{"issue":"6","key":"10.1053\/j.gastro.2020.06.039_bib29","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181231","article-title":"An updated association between TNF-alpha -238G\/A polymorphism and gastric cancer susceptibility in East Asians","volume":"38","author":"Zhao","year":"2018","journal-title":"Biosci Rep"},{"key":"10.1053\/j.gastro.2020.06.039_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2013.06.017","article-title":"Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically","volume":"24","author":"Putoczki","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1053\/j.gastro.2020.06.039_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ydbio.2008.10.025","article-title":"The gastric epithelial progenitor cell niche and differentiation of the zymogenic (chief) cell lineage","volume":"325","author":"Bredemeyer","year":"2009","journal-title":"Dev Biol"},{"key":"10.1053\/j.gastro.2020.06.039_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3904\/kjim.2016.021","article-title":"Diagnosis and management of gastric dysplasia","volume":"31","author":"Sung","year":"2016","journal-title":"Korean J Intern Med"},{"key":"10.1053\/j.gastro.2020.06.039_bib33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gut.45.5.784","article-title":"Gastric epithelial dysplasia","volume":"45","author":"Lauwers","year":"1999","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2020.06.039_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-62703-005-2_22","article-title":"Histologic scoring of gastritis and gastric cancer in mouse models","volume":"921","author":"Rogers","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1053\/j.gastro.2020.06.039_bib35","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0016-5085(00)70361-1","article-title":"Reversible drug-induced oxyntic atrophy in rats","volume":"118","author":"Goldenring","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.06.039_bib36","first-page":"A92","article-title":"Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in normal and gastrin knockout mice","volume":"126","author":"Nomura","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.06.039_bib37","first-page":"251","article-title":"Gastric cancer: classification, histology and application of molecular pathology","volume":"3","author":"Hu","year":"2012","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1053\/j.gastro.2020.06.039_bib38","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.3892\/ol.2017.6736","article-title":"Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer","volume":"14","author":"Shan","year":"2017","journal-title":"Oncol Lett"},{"issue":"7517","key":"10.1053\/j.gastro.2020.06.039_bib39","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","year":"2014","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2020.06.039_bib40","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.3748\/wjg.v22.i28.6373","article-title":"Immunological battlefield in gastric cancer and role of immunotherapies","volume":"22","author":"Wang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.06.039_bib41","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2020.06.039_bib42","first-page":"561","article-title":"Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations","volume":"6","author":"Raufi","year":"2015","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1053\/j.gastro.2020.06.039_bib43","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2147\/DDDT.S75152","article-title":"Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer","volume":"9","author":"Qing","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1053\/j.gastro.2020.06.039_bib44","doi-asserted-by":"crossref","first-page":"24269","DOI":"10.18632\/oncotarget.8169","article-title":"PD-L1 is an independent prognostic predictor in gastric cancer of Western patients","volume":"7","author":"Boger","year":"2016","journal-title":"Oncotarget"},{"key":"10.1053\/j.gastro.2020.06.039_bib45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI30111","article-title":"Inflammation, atrophy, and gastric cancer","volume":"117","author":"Fox","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2020.06.039_bib46","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.gastro.2020.06.039_bib47","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12885-017-3310-9","article-title":"Circulating blood levels of IL-6, IFN-\u03b3, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study","volume":"17","author":"Sanchez-Zauco","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1053\/j.gastro.2020.06.039_bib48","first-page":"7360","article-title":"Expression profile of cytokines in gastric cancer patients using proteomic antibody microarray","volume":"14","author":"Quan","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1053\/j.gastro.2020.06.039_bib49","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cyto.2016.08.032","article-title":"Immunohistochemical expression and localization of cytokines\/chemokines\/growth factors in gastric cancer","volume":"89","author":"Raja","year":"2017","journal-title":"Cytokine"},{"key":"10.1053\/j.gastro.2020.06.039_bib50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/mi.2008.26","article-title":"IL-22 in mucosal immunity","volume":"1","author":"Ouyang","year":"2008","journal-title":"Mucos Immunol"},{"key":"10.1053\/j.gastro.2020.06.039_bib51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/CMR.00011-10","article-title":"Helicobacter pylori and gastric cancer: factors that modulate disease risk","volume":"23","author":"Wroblewski","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1053\/j.gastro.2020.06.039_bib52","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1038\/onc.2013.334","article-title":"Signaling mediated by the NF-\u03baB sub-units NF-\u03baB1, NF-\u03baB2 and c-Rel differentially regulate Helicobacter felis-induced gastric carcinogenesis in C57BL\/6 mice","volume":"32","author":"Burkitt","year":"2013","journal-title":"Oncogene"},{"key":"10.1053\/j.gastro.2020.06.039_bib53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jcmgh.2017.01.003","article-title":"Gastric cancer genomics: advances and future directions","volume":"3","author":"Katona","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.06.039_bib54","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1074\/mcp.M600170-MCP200","article-title":"Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays","volume":"5","author":"Ellmark","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"10.1053\/j.gastro.2020.06.039_bib55","first-page":"869","article-title":"Expression of interleukin (IL)-11 and IL-11 receptor in human colorectal adenocarcinoma: IL-11 up-regulation of the invasive and proliferative activity of human colorectal carcinoma cells","volume":"29","author":"Yoshizaki","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1053\/j.gastro.2020.06.039_bib56","first-page":"825","article-title":"Expression of interleukin-11 (IL-11) and IL-11 receptor \u03b1 in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells","volume":"30","author":"Nakayama","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1053\/j.gastro.2020.06.039_bib57","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1158\/1078-0432.CCR-13-2492","article-title":"Molecular pathways: IL11 as a tumor-promoting cytokine-translational implications for cancers","volume":"20","author":"Ernst","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.gastro.2020.06.039_bib58","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3892\/ijo.2012.1486","article-title":"Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3","volume":"41","author":"Lay","year":"2012","journal-title":"Int J Oncol"},{"key":"10.1053\/j.gastro.2020.06.039_bib59","first-page":"1727","article-title":"STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice","volume":"118","author":"Ernst","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2020.06.039_bib60","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ni1576","article-title":"TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes","volume":"9","author":"Yarilina","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1053\/j.gastro.2020.06.039_bib61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.gastro.2020.06.039_bib62","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/annonc\/mdn054","article-title":"A\u00a0clinical study assessing the tolerability and biological effects of infliximab, a TNF-\u03b1 inhibitor, in patients with advanced cancer","volume":"19","author":"Brown","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1053\/j.gastro.2020.06.039_bib63","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s13075-014-0449-5","article-title":"The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study","volume":"16","author":"Wu","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1053\/j.gastro.2020.06.039_bib64","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1185\/03007995.2015.1011778","article-title":"Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk","volume":"31","author":"Lebrec","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1053\/j.gastro.2020.06.039_bib65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldy029","article-title":"The role of neutrophils in cancer","volume":"128","author":"Grecian","year":"2018","journal-title":"Br Med Bull"},{"key":"10.1053\/j.gastro.2020.06.039_bib66","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood-2007-05-087833","article-title":"The dual effects of TNF\u03b1 on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1","volume":"111","author":"Cross","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.gastro.2020.06.039_bib67","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3390\/cancers11040564","article-title":"Tumor-associated neutrophils in cancer: going pro","volume":"11","author":"Wu","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.gastro.2020.06.039_bib68","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ccell.2016.10.010","article-title":"Deubiquitination and stabilization of PD-L1 by CSN5","volume":"30","author":"Lim","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1053\/j.gastro.2020.06.039_bib69","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1038\/s41467-017-02358-7","article-title":"TNF\u03b1 blockade overcomes resistance to anti-PD-1 in experimental melanoma","volume":"8","author":"Bertrand","year":"2017","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"10.1053\/j.gastro.2020.06.039_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08977194.2019.1620227","article-title":"Emerging roles for interleukin-11 in disease","volume":"37","author":"Nguyen","year":"2019","journal-title":"Growth Factors"},{"key":"10.1053\/j.gastro.2020.06.039_bib71","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0092-8674(95)90415-8","article-title":"Targeted disruption of the p50 subunit of NF-kB leads to multifocal defects in immune responses","volume":"80","author":"Sha","year":"1995","journal-title":"Cell"},{"issue":"6469","key":"10.1053\/j.gastro.2020.06.039_bib72","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/368339a0","article-title":"Impaired immune and acute-phase responses in interleukin-6-deficient mice","volume":"368","author":"Kopf","year":"1994","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2020.06.039_bib73","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1182\/blood.V90.6.2148","article-title":"Adult mice with targeted mutation of the interleukin-11 receptor (IL11Ra) display normal hematopoiesis","volume":"90","author":"Nandurkar","year":"1997","journal-title":"Blood"},{"issue":"7128","key":"10.1053\/j.gastro.2020.06.039_bib74","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2020.06.039_bib75","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1002\/eji.1830271020","article-title":"Distinct roles for lymphotoxin-\u03b1 and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue","volume":"27","author":"K\u00f6rner","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1053\/j.gastro.2020.06.039_bib76","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.immuni.2018.03.003","article-title":"Loss of NF-\u03baB1 causes gastric cancer with aberrant inflammation and expression of immune checkpoint regulators in a STAT-1-dependent manner","volume":"48","author":"O\u2019Reilly","year":"2018","journal-title":"Immunity"},{"key":"10.1053\/j.gastro.2020.06.039_bib77","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2013.06.017","article-title":"Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically","volume":"24","author":"Putoczki","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1053\/j.gastro.2020.06.039_bib78","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-62703-005-2_22","article-title":"Histologic scoring of gastritis and gastric cancer in mouse models","volume":"921","author":"Rogers","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1053\/j.gastro.2020.06.039_bib79","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s13059-014-0480-5","article-title":"FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer","volume":"15","author":"Fu","year":"2014","journal-title":"Genome Biol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001650852034840X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001650852034840X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:42:21Z","timestamp":1777405341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001650852034840X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S001650852034840X"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2020.06.039","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of NFKB1 Results in Expression of Tumor Necrosis Factor and Activation of Signal Transducer and Activator of Transcription 1 to Promote Gastric Tumorigenesis in Mice","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2020.06.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute","name":"copyright","label":"Copyright"}]}}